Skip to main content

Table 8 Mortality among each group

From: Anti-reflux surgery in neonates and infants: analysis of indications, outcomes, and link to mortality among primary and secondary gastroesophageal reflux patients

Item

Primary group

(n = 13)

Secondary group

(n = 33)

Total

(n = 46)

Survivors

13 (100%)

25 (75.8%)

38 (82.6%)

Mortality

0 (0%)

8 (24.2%)

8 (17.4%)